Amoun Pharmaceutical Company S.A.E.
Amoun Pharmaceutical Company S.A.E., commonly referred to as Amoun, is a leading player in the pharmaceutical industry, headquartered in Egypt. Established in 1975, the company has grown to become a significant contributor to the healthcare sector, with a strong presence across the Middle East and North Africa. Amoun specialises in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including prescription medications, over-the-counter drugs, and dietary supplements. Its commitment to quality and innovation has positioned it as a trusted name in the market, with a portfolio that addresses various therapeutic areas. With numerous accolades and a robust market position, Amoun continues to enhance its reputation through strategic partnerships and a focus on research and development, ensuring it meets the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Amoun Pharmaceutical Company S.A.E.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amoun Pharmaceutical Company S.A.E.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Amoun Pharmaceutical Company S.A.E.'s reported carbon emissions
Amoun Pharmaceutical Company S.A.E., headquartered in Egypt, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company at this time. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes initiatives aimed at reducing carbon footprints and enhancing environmental responsibility. However, without concrete information from Amoun Pharmaceutical Company S.A.E., it is challenging to detail their specific climate commitments or initiatives. For stakeholders and environmentally conscious consumers, it is advisable to monitor the company's future disclosures for any updates on their carbon emissions and sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amoun Pharmaceutical Company S.A.E. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
